Consistent, defined and scalable human iPSC-derived disease models for Parkinson's and Gaucher disease research and drug discovery
Powered by opti-ox
Powered by opti-ox
Parkinson’s disease is a progressive neurodegenerative disorder that causes tremors, slow movement, stiffness and neurological decline. Gaucher disease is a lysosomal disorder that shares genetic risk factors with Parkinson’s disease. In both diseases, pathology begins years before clinical symptoms, making it difficult to both study their development and identify effective therapeutics that halt their progression.
There is a pressing need for human in vitro Parkinson’s and Gaucher disease models to identify new therapeutics that could halt or reverse their devastating effects. ioDisease Model Cells from bit.bio provide scientists with defined, consistent, and scalable sources of iPSC-derived human neurons engineered with common monogenic mutations associated with Parkinson’s and Gaucher disease.
Discover ioDisease Model Cells for Parkinson’s and Gaucher disease research below.
Generate any knockout mutation related to Parkinson’s and Gaucher disease with CRISPR-Ready ioCells. These cells have Cas9 constitutively expressed, enabling scientists to easily generate gene knockouts in physiologically relevant cells in a matter of days.
Access our platform to generate custom disease model cells to answer your drug discovery or disease research questions.